According to Paratek Pharmaceuticals
's latest financial reports the company's current revenue (TTM ) is HK$1.30 Billion. In 2022 the company made a revenue of HK$1.17 Billion an increase over the revenue in the year 2021 that were of HK$0.94 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | HK$1.31 B | 11.5% |
2022 | HK$1.17 B | 24.92% |
2021 | HK$0.94 B | 179.56% |
2020 | HK$0.33 B | 161.83% |
2019 | HK$0.12 B | -3.88% |
2018 | HK$0.13 B | 35.99% |
2017 | HK$98.56 M | 43731.08% |
2016 | HK$0.22 M | |
2015 | N/A | -100% |
2014 | HK$33.67 M | 148.61% |
2013 | HK$13.54 M | -84.15% |
2012 | HK$85.46 M | -44.13% |
2011 | HK$0.15 B | 57.24% |
2010 | HK$97.27 M | 140.9% |
2009 | HK$40.38 M | -91.38% |
2008 | HK$0.46 B | |
2005 | HK$0.43 M | -95.01% |
2004 | HK$8.7 M |